Major technological and scientific advances have opened a new era in neurosurgical therapies for people with epilepsy, movement, and psychiatric disorders. These invasive surgical procedures provide the unique ability to record and stimulate neuronal populations in precise brain regions, offering groundbreaking opportunities to explore how our brains perform a wide array of cognitive functions. InBRAIN connects state-of-the-art clinical and research activities in intracranial human neuroscience at MGH with MIT’s expertise in engineering (signal processing, artificial intelligence, electrode design) and basic research on the brain (computational models of neural information processing, primate neurophysiology, cognitive neuroscience).
Company Details
- Founded
- -
- Address
- Boston, Massachusetts , Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://bcs.mit.edu/inbrain
- Keywords
- Cambridge.
- HQ
- Boston, Massachusetts
Mgh-Mit Inbrain Collaboration Questions
Mgh-Mit Inbrain Collaboration's website is https://bcs.mit.edu/inbrain
Mgh-Mit Inbrain Collaboration's LinkedIn profile is https://www.linkedin.com/company/mgh-mit-inbrain-collaboration
Mgh-Mit Inbrain Collaboration's industry is
Biotechnology Research
Mgh-Mit Inbrain Collaboration's top competitors are
Spotify,
Blackrock Neurotech,
Synchron,
Openbci,
Inbrain.ai,
Inbrain Neuroelectronics,
Boston Dynamics,
Brain Modulation Lab,
Mit Brain And Cognitive Sciences.
Mgh-Mit Inbrain Collaboration's categories are Biotechnology Research
Mgh-Mit Inbrain Collaboration's founding year is 2020
